Laboratories. Luminata TM Classico, Crescendo and Forte Western HRP Substrate were purchased from Merck Millipore Corporation. Pan Caspase Inhibitor z-VAD-fmk was purchased from R&D Systems TM . All other chemicals used were purchased from Sigma-Aldrich (Singapore).
General instrumentation.
1 H NMR spectrums were obtained using a Bruker Avance 300 spectrometer and the chemical shifts (δ) were reported in parts per million with reference to residual solvent peaks. Electrospray-ionization Mass Spectrometry (ESI-MS) spectra were obtained using Thermo Finnigan MAT ESI-MS System. UV-vis spectra were obtained using the Shimadzu UV-1800 UV Spectrophotometer. Ru concentrations were determined using the Optima ICP-OES (Perkin-Elmer) operated by CMMAC, NUS. Elemental analyses of selected Ru complexes were carried out using a Perkin-Elmer PE 2400 elemental analyzer by CMMAS, NUS.
Absorbance on 96-well plates were measured using BioTek® Synergy H1 Hybrid Reader.
Western blot proteins bands were visualized via enhanced chemiluminescence imaging (PXi, Syngene). Ultrapure water was purified by a Milli-Q UV purification system (Sartorius Stedim Biotech SA). 
HPLC analysis of compound purity (assembly yield

Inhibition of Cell Viability (Screening).
The anti-proliferation activity of the 195 RAS complexes on exponentially growing cancer cells were screened using a modified MTT assay.
HCT116 cells and TC7 were seeded at 5000 cells/100 μL per well and 4000 cells/100 µL per well respectively, in Corning® Costar® 96-well plates and incubated for 24 h. Subsequently, the seeded cells were exposed to the library of RAS complexes in a predetermined order, at a single concentration of 25 µM 1% (v/v) DMSO and incubated for 48 h at 37 °C, 5% CO2. After 48 h, the medium was aspirated and replaced with MTT solution in complete DMEM media (100 μL, 0.5 mg/mL) and incubated for an additional 45 min at 37 °C, 5% CO2. Subsequently, the medium was aspirated, and the purple formazan crystals dissolved in DMSO (100 μL). The absorbance due to the dissolved purple formazan was than obtained at 570 nm. The cell viabilities associated with each RAS complex were calculated from the measured absorbance of three replicate, with reference to untreated controls.
Synthesis of 532m and 532p. The bulk synthesis of 532m and 532p was done in one-pot manner similar to the plate synthesis, except that final volume of the reaction mixture was scaled up from 200 µL to 20 mL. The DMSO/H2O solvent mixture was then lyophilized over 48 h. The resulting brown viscous liquid was reconstituted in minimal amount of chloroform and purified by silica gel colomn chromatography (Gradient elution: 1:4 v/v EtOH/CHCl3, Rf = 0.5; 1:3 v/v EtOH/CHCl3, Rf = 0.7). The final product was then dried in vacuo for 1 h to give a deep red solid.
The products were determined to be > 95% pure by elemental analysis. Only compounds with assembly yield (purity) greater than 70% and cell viability lesser than 50% in HCT116 were chosen for the screen. Figure S5 . Cell viability curves from secondary screening. 22 initial hits from the single-concentration screens were tested at a range of concentrations in both HCT116 (apoptosis-sensitive) and TC7 (apoptosis-resistant) to obtain their cell viability curves. The estimated IC50 values from one set of experiments was used to identify the two apoptosis-independent lead compound, 532m and 532p. Figure S6 . 1 H NMR spectrum of 532m. Spectrum was acquired using a 300 MHz spectrometer in DMSO-d6. The formation of the imine peak around 9.0 ppm is indicative of the formation of the complex. Residual solvent peaks are as indicated.
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Figure S7. 13 C NMR spectrum of 532m. Spectrum was acquired using a 500 MHz spectrometer in DMSO-d6. 
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Figure S11. 13 C NMR spectrum of 532p. Spectrum was acquired using a 500 MHz spectrometer in DMSO-d6. Table S1 . % Assembly Yield (Purity) of each RAS complex, determined by HPLC analysis. Table S2 . HCT116 cell viability data after single-concentration (25 µM) screen with 166 RAS complexes of sufficient purity.
